The American Diabetes Association and The Leapfrog Group Recognize Hospitals Offering High-Quality Care for People Living with Diabetes

Why It Matters

Hospital recognition highlights institutions that reduce severe complications for the 8 million diabetic patients hospitalized each year, driving broader adoption of evidence‑based diabetes care and improving patient safety nationwide.

Key Takeaways

• 37 hospitals in 14 states earned 2026 Recognized Leader designation
• Program aligns ADA’s 2026 Standards of Care with Leapfrog safety metrics
• Recognized hospitals implement glucose testing, hypoglycemia protocols, and discharge planning
• Approximately 8 million diabetic patients are hospitalized annually, facing high complication risk
• Applications for 2027 recognition open July 1, deadline Jan 31, 2027

Pulse Analysis

Diabetes remains a leading chronic condition in the United States, with more than 155 million Americans living with diabetes or prediabetes. Each year roughly 8 million of these individuals are admitted to hospitals, where they confront a heightened risk of complications such as hypoglycemia, infections, amputations, and even mortality. The American Diabetes Association (ADA) and The Leapfrog Group’s joint Recognized Leader program shines a spotlight on hospitals that have built robust systems to mitigate these risks. By publicly acknowledging best‑in‑class facilities, the initiative creates a benchmark for safe, high‑quality inpatient diabetes management.

To earn the 2026 Recognized Leader title, hospitals must demonstrate compliance with the ADA’s 2026 Standards of Care and Leapfrog’s patient‑safety metrics. Evaluations cover systematic blood‑glucose testing, proactive hypoglycemia protocols, tailored insulin regimens, pre‑operative preparation, and comprehensive discharge planning for high‑risk patients. The assessment also samples real‑world outcomes, ensuring that documented processes translate into measurable reductions in medication errors and infection rates. For participating institutions, the designation not only validates clinical excellence but also enhances reputation, potentially influencing payer contracts and attracting patients seeking specialized diabetes care.

The list of 37 recognized hospitals spans 14 states, from academic centers in Illinois to community health systems in North Carolina, illustrating that high‑quality diabetes care is achievable across diverse market segments. As health systems compete on quality scores and value‑based reimbursement, the Recognized Leader badge offers a competitive edge and may drive broader adoption of the ADA’s evidence‑based protocols. With the 2027 application window opening in July, hospitals that have yet to participate will likely accelerate investments in diabetes safety programs to capture similar benefits.